VTRS
NASDAQ · Pharmaceuticals
Viatris Inc
$17.17
-0.22 (-1.27%)
Performance
1D
—
1W
—
1M
—
3M
+10.35%
6M
+68.83%
1Y
+95.78%
YTD
+37.80%
Open$17.30
Previous Close$17.39
Day High$17.53
Day Low$16.65
52W High$17.45
52W Low$8.19
Volume—
Avg Volume15.05M
Market Cap19.70B
P/E Ratio—
EPS$-2.96
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$13.14
Above
SMA 200
$10.55
Above
RSI (14)
87.6
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
18 analysts
Price Target
+615.3% upside
Current
$17.17
$17.17
Target
$122.82
$122.82
$69.38
$122.82 avg
$167.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.02B | 14.63B | 3.47B |
| Net Income | -3,445,393,540 | -3,236,799,776 | 966.90M |
| Profit Margin | -24.6% | -23.4% | 27.9% |
| EBITDA | -387,526,445 | -384,290,316 | 1.51B |
| Free Cash Flow | — | — | 925.81M |
| Rev Growth | -4.2% | -4.2% | -2.8% |
| Debt/Equity | 0.98 | 0.98 | 0.35 |
Dividend
Dividend Yield3.09%
Annual Dividend$0.48
Payout Ratio28.5%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |